(Reuters Health) – Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.
(Reuters) – The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher’s disease, by eliminating the need for certain trials and minimizing patient enrollment.
(Reuters) – The largest U.S. health insurer UnitedHealth Group Inc will buy DaVita Inc’s primary and urgent care services for $4.9 billion in its second acquisition this year to expand its fast-growing medical group, it said on Wednesday.
(Reuters) – The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
LONDON (Reuters) – Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government’s industrial strategy plans after Brexit.
(Reuters Health) – Whether it’s colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.
SAO PAULO (Reuters) – Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.
ASUNCION (Reuters) – Paraguay’s Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.
(Reuters Health) – Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.
(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S’s diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co’s Trulicity.